Skip to main content

Table 2 Assessment schedule (time in weeks)

From: The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample

 

B

Stabilization

O

Maintenance

 

-1

0

4

8

12

14

16

Q 2 wks × 8 wks then monthly visits

Cross over to Valproic Acid for mood episode on lithium

CGI-S-BP by doctor

X

X

X

X

X

X

X

X

X

Mood episode checklist

X

X

X

X

X

X

X

X

X

Consent

X

        

MINI- PLUS

X

        

Demographics/course of illness

X

        

HAM-A

 

X

  

X

 

X

 

X

MADRS

 

X

X

 

X

 

X

X

X

QIDS-SR 16

X

X

X

X

X

X

X

X

X

YMRS/CARS – M

 

X

X

 

X

  

X

X

Side Effects Survey

X

X

X

X

X

X

X

X

X

Q-LES-Q

X

   

X

 

X

 

X

IRS

X

   

X

 

X

 

X

MSSI

X

X

X

 

X

 

X

 

X

Serious Adverse Event Form

X

X

X

X

X

 

X

X

X

  1. O observation phase, B baseline, ET Early Termination, Mini-PLUS Extended Mini-International Neuropsychiatric Interview, MADRS Montgomery Asberg Depression Rating Scale, QIDS-SR 16 Quick Inventory of Depressive Symptomatology Self-Report, YMRS Young Mania Rating Scale, CARS-M: Clinician Administered Rating Scale for Mania, HAM-A Hamilton Anxiety Rating Scale, CGI-BP Clinical Global Impressions of Severity - Bipolar Version, Q-LES-Q quality of life, enjoyment, and satisfaction questionnaire, IRS impulsivity rating scale, MSSI The Modified Scale of Suicidal Ideation